Navigation Links
Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: 'Health IT: Empowering Precision Medicine'
Date:3/16/2009

WASHINGTON, March 16 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) Chairman and CEO David B. Snow Jr. is scheduled to deliver the Keynote Luncheon Address to the American Enterprise Institute's health care conference entitled, "Can Health IT Improve Care?" on Wednesday, March 18, 2009, at 12:30 p.m.

Through the stimulus package, $19 billion of new federal funding will be directed at expanding the use of health information technology. Snow will articulate a compelling plan that leverages this investment to set our nation on a path to comprehensive, workable health care reform -- empowering a new generation of precision medicine. With more than 30 years experience in the health care industry, Snow is an innovative and provocative thought leader whose candid views on health reform have generated deep interest in Washington and beyond. 


    WHO:     Medco Chairman and CEO David B. Snow Jr.

    WHAT:    Address before American Enterprise Institute (AEI):
             "Health IT: Empowering Precision Medicine"

    WHEN:    Wednesday, March 18, 2009 @ 12:30 p.m.

    WHERE:   American Enterprise Institute
             Wohlstetter Conference Center, 12th Floor
             1150 Seventeenth Street NW
             Washington, DC 20036

    RSVP:    Media attendees are required to register for this event.
             Please contact Sara Huneke at AEI:
             sara.huneke@aei.org or (202) 862-4870

About Medco

Medco Health Solutions, Inc (NYSE: MHS) is a leading health care company, serving the needs of more than 60 million people. Medco, the world's most advanced pharmacy(R), provides clinically driven pharmacy s
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
2. AUDIO from Medialink and Kelloggs: Whats in Your Water?
3. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
6. Weiner Public News First Media Team at National Press Club 5K
7. VIDEO from Medialink and General Motors: On and Off the Track
8. HealthMedia Revolution Explodes in Second Quarter
9. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
10. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
11. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and dying hospitalized children ask their physicians to pray ... to such personal requests? While increasing numbers of physicians ... families cope with serious illness, a new study reports ... who raise the issue of prayer, not the doctors ... Medical Journal , Brandeis and Rice University sociologists report ...
(Date:12/16/2009)... agency, is honored to announce that Chris Wepfer and Jackie ... Year in Healthcare Traveler magazine’s 2009 Recruiters of the Year ... received such honors and the first for Jackie. , ... ... Solutions, a national healthcare staffing agency, is honored to announce ...
(Date:12/16/2009)... For ages, people from around the world have visited ... waters have a reputation that dates back over 2000 ... Now, with the introduction of two bath salt lines ... legendary benefits of Dead Sea salt in their own ... Dead Sea salt and essential oils - but no ...
(Date:12/16/2009)... BOCA RATON, Fla., Dec. 16 Dale Buchanan, owner ... has decided to have a weight loss contest for his ... is that the students are not competing for their own ... to raise money for the Tri County Humane Society ... each student of mine loses between January 4 and February ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
Breaking Medicine News(10 mins):Health News:Prayer on the hospital floor 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:Pros and Cons of Electronic Medical Records Weighed 2
... Shows Stellar 92 Percent Effective Rate; First For ... lice" become more resistant to some pharmaceutical remedies, ... all-natural head lice product line, Rosemary Repel Hair ... preventing lice from infesting hair follicles.In an in-vitro ...
... is reduced in rodent models of liver injury, ... sulphide, two factors that contribute to endothelial dysfunction ... study the analysis of the human Cystathionase gene ... sequence. Administration of an FXR ligand to carbon ...
... peptide (NP) receptor type B (NPR-B) gene was ... diabetic rats and the expression was increased in ... pGC-cGMP signal is up-regulated and it may contribute ... , Gastroparesis (delayed gastric emptying) is frequent in ...
... Practice and an alliance of businesses in Bucks County, ... and their staff more time to devote to patient ... to help doctors in Bucks County better handle the ... Members of the Bucks County Partners include Doylestown Hospital, ...
... Fixed-dose combination offers a convenient option that may ... pressure goals while decreasing patient pill burden(1)PARSIPPANY, N.J., ... that the United States Food and Drug Administration ... and olmesartan medoxomil) as initial or ,first-line, therapy ...
... Inc. (Nasdaq: GTIV ), a leading provider of ... present at the Deutsche Bank 34th Annual Health Care Conference ... May 19, 2009. The presentations will be available to the ... accessed by visiting http://investors.gentiva.com/events.cfm . ...
Other Medicine News:Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2Health News:Farnesoid X receptor regulates cystathionase 2Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 2Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 3Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 5Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 6Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 2Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 3
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Mass., Dec. 16 According to Millennium ... technology market intelligence, health care reforms in China ... market in 2009, and will continue to fuel ... Asia Pacific Markets for Interventional Cardiology Devices ... the Chinese government will allow the Chinese drug-eluting ...
(Date:12/16/2009)... /PRNewswire/ -- Sanofi Pasteur, the ... today that it has entered into an ... develop and commercialize its prophylactic vaccine against ... aureus or MRSA. MRSA are responsible ... referred to as multidrug-resistant Staphylococcus aureus ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 1Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 2Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 3Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 1Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 2LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 1LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 2
... EPOC Results Published in March 22 Issue ... March 20 Sanofi-aventis,today announced that efficacy ... Intergroup study published in the March 22 ... patients Eloxatin(R) (oxaliplatin injection) in,combination with 5-fluorouracil/leucovorin ...
... NanoBio Corporation,announced today that it has seen promising ... study of NB-002, a topical lotion for onychomycosis ... clearly,justify completing the study, according to NanoBio scientists., ... out a clear nail after,successfully treating the infection ...
Other Medicine Technology:Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 2Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 3Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 4Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 5NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
... for ELISA testing. The system consists of ... Robot, and 1 Plate hotel. The Dade ... of samples from primary tubes via the ... robotic transport system and plate processing via ...
... The Genesis RMP is ideal for ... as for reference and pharmaceutical laboratories. It ... available ELISA and EIA assays from different ... annual throughput of up to 600'000 tests, ...
... IMMULITE and IMMULITE 1000 assays ... the IMMULITE and IMMULITE 1000, ... which offer simplicity in both ... can be found in a ...
... ENA Enzyme-Linked Immunosorbent Assay (ELISA) is intended for ... La, Scl-70, and Jo-1 in human sera. ... detect antibodies in a single serum specimen. ... used as an aid to the diagnosis of ...
Medicine Products: